知情人士称，主权财富基金和纯多头投资者（这类投资者通常投资于预期会上涨的股票，而不从事做 空）已表达出足以买下澜起科技香港上市发售的所有股票的兴趣。股票已获多倍认购。 ...

（注：上述数据截止日为2026年01月27日。） 投资者可登录国投瑞银基金管理有限公司网站http://www.ubssdic.com，或拨打客户服务电话：400-880- 6868咨询相关信息。 特此公告。 登录新浪财经APP 搜索【信披】查看更多考评等级 国投瑞银基金管理有限公司（以下简称本公司）旗下基金参加了深圳麦格米特电气股份有限公司（以下 简称麦格米特，代码：002851.SZ）非公开发行股票的认购。麦格米特已发布《深圳麦格米特电气股份 有限公司向特定对象发行股票发行情况报告书》，根据中国证监会《公开募集证券投资基金信息披露管 理办法》《关于基金投资非公开发行股票等流通受限证券有关问题的通知》等有关规定，现将本公司旗 下基金投资麦格米特非公开发行股票的相关信息公告如下： ■ 4、本基金二级市场的交易价格，除了有基金份额净值波动的风险外，还会受到市场供求关系、系统性 风险、流动性风险等其他因素的影响，可能使投资者面临损失。 风险提示：基金管理人承诺以诚实信用、勤勉尽责的原则管理和运用基金资产，但不保证基金一定盈 利，也不保证最低收益。销售机构根据法规要求对投资者类别、风险承受能力和基金的风险等级进行划 ...

Core Viewpoint - The company, Youran Dairy (09858), is engaging in a share placement and subscription agreement, with a share price set at HKD 3.92, which represents an approximate 8.84% discount from the last trading price of HKD 4.30 [1][2]. Group 1: Share Placement and Subscription Details - On January 16, 2026, the company entered into a placement and subscription agreement, where the seller will sell shares and the placement agent will facilitate the sale to at least six subscribers at a price of HKD 3.92 per share [1]. - The company will issue new shares equivalent to the number of shares sold under the placement agreement at the same price of HKD 3.92 per share [1]. - The estimated net proceeds from the subscription are expected to be approximately HKD 11.72 billion [2]. Group 2: Share Capital Impact - The placement shares will represent about 7.14% of the company's enlarged issued share capital after the completion of the subscription [2]. - The total issued share capital after the placement and subscription will be approximately 6.66% larger than before [2]. - The number of shares to be subscribed under the special authorization agreement is 299 million, which will also represent about 7.14% of the enlarged issued share capital [2].

Group 1 - Tian Sheng New Materials (300169.SZ) announced a share transfer agreement on January 14, 2026, where Rongsheng Xintai will acquire a total of 20.4895 million shares from Sun Jian and Lü Zewei at a price of 6.39 yuan per share, representing 3.47% and 2.81% of the company's total shares respectively [1][2] - Following the share transfer, Rongsheng Xintai will hold 6.29% of the company's total shares [1] - On the same day, the company signed a conditional share subscription agreement with Rongsheng Zhirui, which plans to subscribe for all 50 million shares issued by the company, resulting in a holding ratio of 13.30% post-issuance [1][2] Group 2 - As a result of these transactions, Rongsheng Zhirui will become the controlling shareholder of the listed company, with Rongsheng Xintai as a concerted actor, and the actual controller Wei Lidong will become the actual controller of the company [2] - The company’s board of directors approved a proposal for a specific object issuance of A-shares, with total fundraising not exceeding 253 million yuan, which will be used to repay bank loans and/or supplement working capital [2] - The company's stock will resume trading on January 16, 2026 [3]

Core Viewpoint - The article discusses the transfer of shares of Innovent Biologics (09939) from Futu Securities International Hong Kong to BOC International Securities, with a total market value of HKD 124 million, representing 11.04% of the shares [1] Group 1: Share Transfer and Agreement - On July 31, shareholders of Innovent Biologics transferred shares valued at HKD 124 million to BOC International Securities, accounting for 11.04% of the total shares [1] - Innovent Biologics announced an agreement with Dr. Tong Youzhi and the seller (KT International Investment Limited) to sell 20.673 million shares at a price of HKD 2.08 per share, which is approximately 4.62% of the company's issued share capital [1] Group 2: Fundraising Purpose - The placement and subscription are aimed at supplementing the long-term funding for the group's general business and growth strategy [1] - The net proceeds from the subscription are estimated to be approximately HKD 40.34 million after deducting related expenses, which will be used for general working capital and business operations [1]